New Immunotherapy Treatment Darzalex For Multiple Myeloma Cancer1

Darzalex (daratumumab) is a recent FDA approved immunotherapy for the treatment of multiple myeloma cancer. In this video, Dr. Stephen Lemon, a medical oncologist, talks about how this immunotherapy treatment works, including what types of side effects it may cause.

Darzalex is developed by Janssen Biotech. Stephen Lemon MD is a medical oncologist who is not affiliated with Janssen Biotech.